44 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
patients with Opportunistic ... Infections • Pulmonary ... count <50 • Pulmonary ... Therapy #HAART #HIV #Opportunistic ... #Infections #management
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Medications #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... #prescribing #Pulmonary ... Hypertension #PAH #Management ... Algorithm #treatment #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology